Clinical trial
Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease (PD)
NCT04387812 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease (PD)
- Lead sponsor
- Tel-Aviv Sourasky Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2020
- Completion date
- December 31, 2024
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gba gene mutation, leucine-rich repeat kinase 2 (lrrk2) gene mutation, parkinson disease